Jump Financial’s Structure Therapeutics GPCR Stock Holding History

Jump Financial’s Portfolio GPCR Stock Details GPCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.29M	Sell	42,658 -65,199	-60%	-$2.88M	0.02%	842
2026 Q1	$5.2M	Buy	+107,857	New	+$7.38M	0.07%	348
2025 Q4	–	Sell	-106,400	Closed	-$2.98M	–	2072
2025 Q3	$2.98M	Buy	106,400 +43,166	+68%	+$860K	0.04%	580
2025 Q2	$1.31M	Buy	63,234 +32,524	+106%	+$715K	0.01%	867
2025 Q1	$532K	Buy	+30,710	New	+$752K	0.01%	1059
2024 Q3	–	Sell	-63,020	Closed	-$2.47M	–	1825
2024 Q2	$2.47M	Buy	+63,020	New	+$2.59M	0.05%	467

Other funds holding GPCR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Jupiter Topco New York $245B AUM

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Jump Financial's GPCR Position: Q2 2026 in Review

Jump Financial reduced its Structure Therapeutics (GPCR) stake by 60% in Q2 2026, selling an estimated $2.88M and leaving 42,658 shares worth $2.29M. The position accounts for 0.02% of the portfolio, ranked #842.

Jump Financial first reported a position in GPCR in Q2 2024 and has held it in 6 quarters since. The position peaked at $5.2M in Q1 2026. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

Jump Financial held 42,658 shares of Structure Therapeutics worth $2.29M as of Q2 2026.
Jump Financial sold 65,199 Structure Therapeutics shares in Q2 2026, an estimated $2.88M.
Structure Therapeutics made up 0.02% of Jump Financial's portfolio in Q2 2026, its #842 holding.
Jump Financial first reported a position in Structure Therapeutics in Q2 2024 and has held it in 6 quarters since.
Jump Financial's Structure Therapeutics position peaked at $5.2M in Q1 2026.
191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.